Evidence map›Paper›PMID 34440896›Full record

ArticleCells2021

Cytotoxic Effects of 5-Azacytidine on Primary Tumour Cells and Cancer Stem Cells from Oral Squamous Cell Carcinoma: An In Vitro FTIRM Analysis.

Valentina Notarstefano, Alessia Belloni, Simona Sabbatini, Chiara Pro, Giulia Orilisi, Riccardo Monterubbianesi, Vincenzo Tosco, Hugh J Byrne, Lisa Vaccari, Elisabetta Giorgini

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  2. About a Possible Impact of Endodontic Infections byInternational journal of molecular sciences · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. [Cancer stem cells in oral squamous cell carcinoma. Literature review].Revista cientifica odontologica (Universidad Cientifica del Sur)
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Valentina NotarstefanoDepartment of Life and Environmental Sciences, Università Politecnica Delle Marche, 60131 Ancona, Italy.ORCID 0000-0002-4651-6235
Alessia BelloniDepartment of Life and Environmental Sciences, Università Politecnica Delle Marche, 60131 Ancona, Italy.ORCID 0000-0003-3953-730X
Simona SabbatiniDepartment of Material, Environmental Sciences and Urban Planning, Università Politecnica Delle Marche, 60131 Ancona, Italy.
Chiara ProDepartment of Life and Environmental Sciences, Università Politecnica Delle Marche, 60131 Ancona, Italy.ORCID 0000-0002-1279-1976
Giulia OrilisiDepartment of Clinical Sciences and Stomatology, Università Politecnica Delle Marche, 60126 Ancona, Italy.
Riccardo MonterubbianesiDepartment of Clinical Sciences and Stomatology, Università Politecnica Delle Marche, 60126 Ancona, Italy.ORCID 0000-0002-3419-665X
Vincenzo ToscoDepartment of Clinical Sciences and Stomatology, Università Politecnica Delle Marche, 60126 Ancona, Italy.ORCID 0000-0002-3378-3844
Hugh J ByrneFOCAS Research Institute, Technological University Dublin, Dublin 8, Ireland.ORCID 0000-0002-1735-8610
Lisa VaccariElettra Sincrotrone Trieste, SISSI Beamline, 34149 Basovizza, Italy.ORCID 0000-0003-2355-114X
Elisabetta GiorginiDepartment of Life and Environmental Sciences, Università Politecnica Delle Marche, 60131 Ancona, Italy.ORCID 0000-0003-0503-5870
Marche Polytechnic University · ITElettra-Sincrotrone Trieste S.C.p.A. · ITTechnological University Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, the cytotoxic effects of 5-azacytidine on primary Oral Squamous Cell Carcinoma cells (OSCCs) from human biopsies, and on Cancer Stem Cells (CSCs) from the same samples, were investigated by an in vitro Fourier Transform InfraRed Microscospectroscopy (FTIRM) approach coupled with multivariate analysis. OSCC is an aggressive tumoral lesion of the epithelium, accounting for ~90% of all oral cancers. It is usually diagnosed in advanced stages, and this causes a poor prognosis with low success rates of surgical, as well as radiation and chemotherapy treatments. OSCC is frequently characterised by recurrence after chemotherapy and by the development of a refractoriness to some employed drugs, which is probably ascribable to the presence of CSCs niches, responsible for cancer growth, chemoresistance and metastasis. The spectral information from FTIRM was correlated with the outcomes of cytotoxicity tests and image-based cytometry, and specific spectral signatures attributable to 5-azacytidine treatment were identified, allowing us to hypothesise the demethylation of DNA and, hence, an increase in the transcriptional activity, together with a conformational transition of DNA, and a triggering of cell death by an apoptosis mechanism. Moreover, a different mechanism of action between OSSC and CSC cells was highlighted, probably due to possible differences between OSCCs and CSCs response.

Indexed as

ApoptosisAzacitidineCarcinoma, Squamous CellCell Line, TumorCell SurvivalDNA MethylationGene Expression Regulation, NeoplasticHumansMouth NeoplasmsSpectroscopy, Fourier Transform InfraredSquamous Cell Carcinoma of Head and NeckTumor Cells, CulturedAzacitidine5-azacytidineDNA methylationFourier Transform InfraRed Microscospectroscopyoral squamous cell carcinomaOSCC cancer stem cellsOSCC primary cells

Identifiers

PMID34440896
PMCPMC8392608
OpenAlexW3195222323

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.